pH-dependent antimicrobial properties of copper oxide nanoparticles in Staphylococcus aureus

International Journal of Molecular Sciences

Volumn 18, Issue 4, 2017, Pages

  Hsueh, Yi Huang ^a   Tsai, Ping Han ^a   Lin, Kuen Song ^a  

^a YUAN ZE UNIVERSITY   (Taiwan)

Author keywords

Copper oxide nanoparticles; EXAFS; Staphylococcus aureus; XANES

Indexed keywords

COPPER OXIDE NANOPARTICLE; PROPIDIUM IODIDE; ANTIINFECTIVE AGENT; COPPER; CUPROUS OXIDE; METAL NANOPARTICLE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL VIABILITY; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; FLOW CYTOMETRY; INFRARED SPECTROSCOPY; NONHUMAN; PH; STAPHYLOCOCCUS AUREUS; X RAY ABSORPTION SPECTROSCOPY; X RAY DIFFRACTION; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SPECIES DIFFERENCE; ULTRASTRUCTURE;

ANTI-INFECTIVE AGENTS; COPPER; HYDROGEN-ION CONCENTRATION; METAL NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; SPECIES SPECIFICITY; STAPHYLOCOCCUS AUREUS; X-RAY DIFFRACTION;

EID: 85017426022     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18040793     Document Type: Article

References (41)

1. Schlievert, P.M.; Shands, K.N.; Dan, B.B.; Schmid, G.P.; Nishimura, R.D. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J. Infect. Dis. 1981, 143, 509–516. [CrossRef] [PubMed]
2. Russo, A.; Concia, E.; Cristini, F.; de Rosa, F.G.; Esposito, S.; Menichetti, F.; Petrosillo, N.; Tumbarello, M.; Venditti, M.; Viale, P.; et al. Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. Clin. Microbiol. Infect. 2016, 22, 27–36. [CrossRef]
3. Rello, J.; Nieto, M.; Solé-Violán, J.; Wan, Y.; Gao, X.; Solem, C.T.; de Salas-Cansado, M.; Mesa, F.; Charbonneau, C.; Chastre, J. Nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus treated with linezolid or vancomycin: A secondary economic analysis of resource use from a Spanish perspective. Medicina Intensiva/Sociedad Espanola de Medicina Intensiva y Unidades Coronarias 2016, 40, 474–482. [CrossRef] [PubMed]
4. Tacconelli, E.; Foschi, F. Does gender affect the outcome of community-acquired Staphylococcus aureus bacteraemia? Clin. Microbiol. Infect. 2017, 23, 23–25. [CrossRef] [PubMed]
5. Howden, B.P.; Ward, P.B.; Charles, P.G.; Korman, T.M.; Fuller, A.; du Cros, P.; Grabsch, E.A.; Roberts, S.A.; Robson, J.; Read, K.; et al. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin. Infect. Dis. 2004, 38, 521–528. [CrossRef] [PubMed]
6. Razzak, M.S.A.; Al-Charrakh, A.H.; AL-Greitty, B.H. Relationship between Lactobacilli and opportunistic bacterial pathogens associated with vaginitis. N. Am. J. Med. Sci. 2011, 3, 185–192. [CrossRef] [PubMed]
7. Schlievert, P.M.; Osterholm, M.T.; Kelly, J.A.; Nishimura, R.D. Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. Ann. Intern. Med. 1982, 96, 937–940. [CrossRef] [PubMed]
8. Parsonnet, J.; Hansmann, M.A.; Delaney, M.L.; Modern, P.A.; Dubois, A.M.; Wieland-Alter, W.; Wissemann, K.W.; Wild, J.E.; Jones, M.B.; Seymour, J.L.; et al. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J. Clin. Microbiol. 2005, 43, 4628–4634. [CrossRef] [PubMed]
9. Bondarenko, O.; Juganson, K.; Ivask, A.; Kasemets, K.; Mortimer, M.; Kahru, A. Toxicity of Ag, CuO and ZnO nanoparticles to selected environmentally relevant test organisms and mammalian cells in vitro: A critical review. Arch. Toxicol. 2013, 87, 1181–1200. [CrossRef] [PubMed]
10. Prabhu, S.; Poulose, E.K. Silver nanoparticles: Mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. Int. Nano Lett. 2012, 2, 1–10. [CrossRef]
11. Hajipour, M.J.; Fromm, K.M.; Ashkarran, A.A.; Jimenez de Aberasturi, D.; de Larramendi, I.R.; Rojo, T.; Serpooshan, V.; Parak, W.J.; Mahmoudi, M. Antibacterial properties of nanoparticles. Trends Biotechnol. 2012, 30, 499–511. [CrossRef] [PubMed]
12. Chatterjee, A.K.; Sarkar, R.K.; Chattopadhyay, A.P.; Aich, P.; Chakraborty, R.; Basu, T. A simple robust method for synthesis of metallic copper nanoparticles of high antibacterial potency against E. coli. Nanotechnology 2012, 23, 085103. [CrossRef] [PubMed]
13. Cho, K.-H.; Park, J.-E.; Osaka, T.; Park, S.-G. The study of antimicrobial activity and preservative effects of nanosilver ingredient. Electrochim. Acta 2005, 51, 956–960. [CrossRef]
14. Jung, W.K.; Koo, H.C.; Kim, K.W.; Shin, S.; Kim, S.H.; Park, Y.H. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl. Environ. Microbiol. 2008, 74, 2171–2178. [CrossRef] [PubMed]
15. Usman, M. Synthesis, characterization, and antimicrobial properties of copper nanoparticles. Int. J. Nanomed. 2013, 8, 4467–4479.
16. Borkow, G.; Gabbay, J. Copper, an ancient remedy returning to fight microbial, fungal and viral infections. Curr. Chem. Biol. 2009, 3, 272–278. [CrossRef]
17. Ahamed, M.; Alhadlaq, H.A.; Khan, M.; Karuppiah, P.; Al-Dhabi, N.A. Synthesis, characterization, and antimicrobial activity of copper oxide nanoparticles. J. Nanomater. 2014, 2014, 17. [CrossRef]
18. Ren, G.; Hu, D.; Cheng, E.W.; Vargas-Reus, M.A.; Reip, P.; Allaker, R.P. Characterisation of copper oxide nanoparticles for antimicrobial applications. Int. J. Antimicrob. Agents 2009, 33, 587–590. [CrossRef] [PubMed]
19. Das, D.; Nath, B.C.; Phukon, P.; Dolui, S.K. Synthesis and evaluation of antioxidant and antibacterial behavior of CuO nanoparticles. Colloids Surf. B Biointerfaces 2013, 101, 430–433. [CrossRef] [PubMed]
20. Wang, Z.; Von Dem Bussche, A.; Kabadi, P.K.; Kane, A.B.; Hurt, R.H. Biological and environmental transformations of copper-based nanomaterials. ACS Nano 2013, 7, 8715–8727. [CrossRef] [PubMed]
21. Gilbertson, L.M.; Albalghiti, E.M.; Fishman, Z.S.; Perreault, F.; Corredor, C.; Posner, J.D.; Elimelech, M.; Pfefferle, L.D.; Zimmerman, J.B. Shape-dependent surface reactivity and antimicrobial activity of nano-cupric oxide. Environ. Sci. Technol. 2016, 50, 3975–3984. [CrossRef] [PubMed]
22. Kaweeteerawat, C.; Chang, C.H.; Roy, K.R.; Liu, R.; Li, R.; Toso, D.; Fischer, H.; Ivask, A.; Ji, Z.; Zink, J.I.; et al. Cu nanoparticles have different impacts in Escherichia coli and Lactobacillus brevis than their microsized and ionic analogues. ACS Nano 2015, 9, 7215–7225. [CrossRef] [PubMed]
23. Azam, A.; Ahmed, A.S.; Oves, M.; Khan, M.; Memic, A. Size-dependent antimicrobial properties of CuO nanoparticles against Gram-positive and-negative bacterial strains. Int. J. Nanomed. 2012, 7, 3527–3535. [CrossRef] [PubMed]
24. 2 to microalgae Pseudokirchneriella subcapitata. Sci. Total Environ. 2009, 407, 1461–1468. [CrossRef] [PubMed]
25. Bondarenko, O.; Ivask, A.; Käkinen, A.; Kahru, A. Sub-toxic effects of CuO nanoparticles on bacteria: Kinetics, role of Cu ions and possible mechanisms of action. Environ. Pollut. 2012, 169, 81–89. [CrossRef] [PubMed]
26. Jo, H.J.; Choi, J.W.; Lee, S.H.; Hong, S.W. Acute toxicity of Ag and CuO nanoparticle suspensions against Daphnia magna: The importance of their dissolved fraction varying with preparation methods. J. Hazard. Mater. 2012, 227, 301–308. [CrossRef] [PubMed]
27. Rao, G.N.; Yao, Y.; Chen, J. Evolution of size, morphology, and magnetic properties of CuO nanoparticles by thermal annealing. J. Appl. Phys. 2009, 105, 093901.
28. Zhao, B.; Liu, P.; Zhuang, H.; Jiao, Z.; Fang, T.; Xu, W.; Lu, B.; Jiang, Y. Hierarchical self-assembly of microscale leaf-like CuO on graphene sheets for high-performance electrochemical capacitors. J. Mater. Chem. A. 2013, 1, 367–373. [CrossRef]
29. 2 composite via co-nanocasting replication method and its improved reactivity towards hydrogen. Mater. Lett. 2010, 64, 1379–1382. [CrossRef]
30. Wu, R.; Ma, Z.; Gu, Z.; Yang, Y. Preparation and characterization of CuO nanoparticles with different morphology through a simple quick-precipitation method in DMAC-water mixed solvent. J. Alloy Compd. 2010, 504, 45–49. [CrossRef]
31. Sievert, D.M.; Ricks, P.; Edwards, J.R.; Schneider, A.; Patel, J.; Srinivasan, A.; Kallen, A.; Limbago, B.; Fridkin, S. Antimicrobial-resistant pathogens associated with healthcare-associated infections summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect. Control Hosp. Epidemiol. 2013, 34, 1–14. [CrossRef] [PubMed]
32. Li, Y.; Zhang, W.; Niu, J.; Chen, Y. Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles. ACS Nano 2012, 6, 5164–5173. [CrossRef] [PubMed]
33. Skov, R.; Smyth, R.; Larsen, A.; Bolmstrôm, A.; Karlsson, A.; Mills, K.; Frimodt-Moller, N.; Kahlmeter, G. Phenotypic detection of methicillin resistance in Staphylococcus aureus by disk diffusion testing and Etest on Mueller-Hinton agar. J. Clin. Microbiol. 2006, 44, 4395–4399. [CrossRef] [PubMed]
34. Juzwa, W.; Duber, A.; Myszka, K.; Białas, W.; Czaczyk, K. Identification of microbes from the surfaces of food-processing lines based on the flow cytometric evaluation of cellular metabolic activity combined with cell sorting. Biofouling 2016, 32, 841–851. [CrossRef] [PubMed]
35. Lytle, F.W. The EXAFS family tree: A personal history of the development of extended X-ray absorption fine structure. J. Synchrotron Radiat. 1999, 6, 123–134. [CrossRef] [PubMed]
36. Ravel, B.; Newville, M. ATHENA and ARTEMIS: Interactive graphical data analysis using IFEFFIT. Phys. Scr. 2005, 2005, 1007. [CrossRef]
37. Ravel, B.; Hester, J.; Solé, V.; Newville, M. Towards data format standardization for X-ray absorption spectroscopy. J. Synchrotron Radiat. 2012, 19, 869–874. [CrossRef] [PubMed]
38. Ravel, B.; Newville, M. ATHENA, ARTEMIS, HEPHAESTUS: Data analysis for X-ray absorption spectroscopy using IFEFFIT. J. Synchrotron Radiat. 2005, 12, 537–541. [CrossRef] [PubMed]
39. Gunawan, C.; Teoh, W.Y.; Marquis, C.P.; Amal, R. Cytotoxic origin of copper (II) oxide nanoparticles: Comparative studies with micron-sized particles, leachate, and metal salts. ACS Nano 2011, 5, 7214–7225. [CrossRef] [PubMed]
40. Li, M.; Zhu, L.; Lin, D. Toxicity of ZnO nanoparticles to Escherichia coli: Mechanism and the influence of medium components. Environ. Sci. Technol. 2011, 45, 1977–1983. [CrossRef] [PubMed]
41. Jiang, W.; Mashayekhi, H.; Xing, B. Bacterial toxicity comparison between nano- and micro-scaled oxide particles. Environ. Pollut. 2009, 157, 1619–1625. [CrossRef] [PubMed]